Subsite-specific risk factors for esophageal and gastric adenocarcinoma

American Journal of Gastroenterology

Volumn 102, Issue 8, 2007, Pages 1596-1602

  Crane, Sarah J ^a   Locke III, G Richard ^b   Harmsen, William S ^a   Diehl, Nancy N ^a   Zinsmeister, Alan R ^a   Melton III, L Joseph ^a   Romero, Yvonne ^a,b   Talley, Nicholas J ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DRUG EXPOSURE; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; HOSPITALIZATION; HUMAN; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT CARE; PRIORITY JOURNAL; SMOKING HABIT; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; PROTON PUMPS; RISK FACTORS; SMOKING; STOMACH NEOPLASMS;

EID: 34547613899     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01234.x     Document Type: Article

References (36)

1. Brown L, Devesa S. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002 11 : 235 56.
2. Locke G, Talley N, Carpenter H, et al. Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology 1995 109 : 1750 6.
3. Blot W, Devesa S, Kneller R, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991 265 : 1287 9.
4. Devesa S, Blot S, Fraumeni J. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998 83 : 2049 53.
5. Wayman J, Forman D, Griffin S. Monitoring the changing pattern of esophago-gastric cancer: Data from a UK regional cancer registry. Cancer Causes Control 2001 12 : 943 9.
6. Wijnhoven B, Louwman M, Tilanus H, et al. Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 2002 14 : 115 22.
7. Crane S, Locke G 3rd., Harmsen W, et al. The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther 2007 25 : 447 53.
8. Siewert J, Feith M, Stein H. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: Relevance of a topographic-anatomic subclassification. J Surg Oncol 2005 90 : 139 46.
9. Melton L. History of the Rochester epidemiology project. Mayo Clin Proc 1996 71 : 266 74.
10. Pera M, Cameron A, Trastek V, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993 104 : 510 3.
11. Conio M, Cameron A, Romero Y, et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 2001 48 : 304 9.
12. Cameron A, Lomboy C, Pera M, et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995 109 : 1541 6.
13. Melton L. The threat to medical-records research. N Engl J Med 1997 337 : 1466 70.
14. Chow W, Finkle W, McLaughlin J, et al. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995 274 : 474 7.
15. Engel L, Chow W, Vaughan T, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003 95 : 1404 13.
16. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999 340 : 825 31.
17. Parker-Pope T. The hidden dangers of heartburn: How a common health problem is quietly becoming an unsuspected killer. Wall Street Journal, October 10, 2005.
18. Stein H, Kauer W, Feussner H, et al. Bile reflux in benign and malignant Barrett's esophagus: Effect of medical acid suppression and Nissen fundoplication. J Gastrointest Surg 1998 2 : 333 41.
19. Pera M, Grande L, Gelabert M, et al. Epithelial cell hyperproliferation after biliopancreatic reflux into the esophagus of rats. Ann Thorac Surg 1998 65 : 779 86.
20. Haigh C, Attwood S, Thompson D, et al. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor. Gastroenterology 2003 124 : 615 25.
21. El-Serag H, Aguirre T, Davis S, et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol 2004 99 : 1877 83.
22. Hillman L, Chiragakis L, Shadbolt B, et al. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Med J Aust 2004 180 : 387 91.
23. Chow W, Blaser M, Blot W, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998 58 : 588 90.
24. Weston A, Badr A, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia and Barrett's adenocarcinoma. Am J Gastroenterol 2000 95 : 387 94.
25. Henrik Simon J, Forsgren A, Berglund G, et al. Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter 2001 6 : 310 6.
26. Vaezi M, Falk G, Peek R, et al. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol 2000 95 : 2206 11.
27. Agreus L, Svardsudd K, Talley N, et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: A population-based study. Am J Gastroenterol 2001 96 : 642 9.
28. Locke G, Talley N, Fett S, et al. Risk facors associated with symptoms of gastroesophageal reflux. Am J Med 1999 106 : 642 9.
29. Nilsson M, Johnson R, Ye W, et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003 290 : 66 72.
30. Jacobson B, Somers S, Fuchs C, et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006 354 : 2340 8.
31. Hampel H, Abraham N, El-Serag H. Meta-analysis: Obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005 143 : 199 211.
32. Chow W, Blot W, Vaughan T, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998 90 : 150 5.
33. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenoarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999 130 : 883 90.
34. Zhang Z, Kurtz R, Sun M, et al. Adenocarcinomas of the esophagus and gastric cardia: Medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev 1996 5 : 761 8.
35. Brown L, Swanson C, Gridley G, et al. Adenocarcinoma of the esophagus: Role of obesity and diet. J Natl Cancer Inst 1995 87 : 847 8.
36. Wu A, Wan P, Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus. Cancer Causes Control 2001 12 : 721 32.